Normal melatonin levels in patients with fibromyalgia syndrome

Journal of Rheumatology

Volumn 25, Issue 3, 1998, Pages 551-555

  Press, Joseph ^a,b,c   Phillip, Moshe ^a,c   Neumann, Lily ^a   Barak, Ronit ^a,c   Segev, Yael ^a,d   Abu Shakra, Mahmud ^a,c   Buskila, Dan ^a,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Pediatric Rheumatic Disease Unit

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d Pediat Diagn Therapeut Ctr Lab

Author keywords

Dolorimetry; Fibromyalgia; Melatonin; Tenderness

Indexed keywords

MELATONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; URINALYSIS;

ADULT; FEMALE; FIBROMYALGIA; HUMANS; MELATONIN; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; REFERENCE VALUES; SYNDROME;

EID: 0031936473     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Brown GM. Light, melatonin and the sleep-wake cycle. J Psychiatry Neurosci 1994;19:345-53.
2. Lewy AJ, Ahmed S, Jackson JML, Sack RI. Melatonin shifts circadian rhythms according to a phase-response curve. Chronobiol Int 1992;9:380-4.
3. Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993;15:1-12.
4. 125I) iodomelatonin binding affinity of melatonin analogues. Psychopharmacol 1995;117:364-70.
5. Dahlitz M, Alvares B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet 1991;337:1121-4.
6. Okawa M, Nanami T, Wada S, et al. Four congenitally blind children with circadian sleep-wake rhythm disorder. Sleep 1987;10:101-10.
7. Weitzman ED, Czeisles CA, Coleman RM, Spielman AJ, Zimmerman JC, Dement W. Delayed sleep phase syndrome: a chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry 1981;38:737-46.
8. Thorpy MJ, Korman E, Spielman AJ, Glovinsky PB. Delayed sleep phase syndrome in adolescents. J Adolesc Health Care 1988;9:22-7.
9. Brown R, Kocsis JH, Caroff HS, et al. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry 1985;132:811-6.
10. Claustrat B, Chazot B, Brun J, Jordan D, Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984;19:1215-28.
11. Cavalo A, Holt KG, Hejazi MS, Richards GE, Meyer WJ. Melatonin circadian rhythm in childhood depression. J Am Acad Child Adolesc Psychiatry 1987;26:395-6.
12. Leone M, Lucini V, D'Amico D, et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalgia 1995;15:224-9.
13. Neuwelt EA, Lewy AJ. Disappearance of plasma melatonin after removal of a neoplastic gland. N Engl J Med 1983;308:1132-5.
14. Attanasio A, Borreli P, Marini P, Cambiaso P, Cappa M, Gupta D. Serum melatonin in children with early and delayed puberty. Neuroendocrinol Lett 1983;5:387-92.
15. Waldhauser F, Boepple PA, Schemper M, Mansfield MJ, Crowley WF. Serum melatonin in central precocious puberty is lower than in age-matched perpubertal children. J Clin Endocrinol Metab 1991;73:793-6.
16. West SX, Oosthvizen JM. Melatonin levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 1992;3:33-40.
17. Arendt J, Bozbely AA, Francy C, Wright J. The effect of chronic small doses of melatonin in the late afternoon on fatigue in man: A preliminary study. Neurosci Lett 1984;45:317-21.
18. Almay BG, von Knorring L, Wetterberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res 1987;22:179-91.
19. Bennett RM, Smythe HA, Wolfe F. Recognizing fibromyalgia. Patient Care 1989;23:60-83.
20. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-72.
21. Smythe HA, Moldofsky M. Two contributions to understanding the "fibrositis" syndrome. Bull Rheum Dis 1977;28:928-31.
22. Smythe HA. Nonarticular rheumatism and psychogenic musculoskeletal syndromes. In: McCarty DJ, editor. Arthritis and Allied Conditions: A Textbook of Rheumatology. Philadelphia: Lea & Febiger, 1989:1241-54.
23. Bengtsson A, Bengtsson M. Regional sympathetic blockade in primary fibromyalgia. Pain 1988;33:161-7.
24. Leventhal LJ, Naides SJ, Freundlich B. Fibromyalgia and parvovirus infection. Arthritis Rheum 1991;34:1319-24.
25. Buskila D, Gladman DD, Langevitz P, Urovitz S, Smythe HA. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 1990;17:1202-6.
26. Bennett RM. Confounding features of the fibromyalgia syndrome: a current perspective of differential diagnosis. J Rheumatol 1989;16 Suppl 19:58-61.
27. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 1992;35:1113-6.
28. Buskila D, Fefer P, Harman-Boehm I, et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women. J Rheumatol 1993; 20:2112-5.
29. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988;32:21-6.
30. McCain GA. Nonmedical treatments in primary fibromyalgia. Rheum Dis Clin North Am 1989;15:73-90.
31. Moldofsky H, Warsh JJ. Plasma tryptophan and musculoskeletal pain in nonarticular rheumatism ("fibrositis syndrome"). Pain 1978;5:65-71.
32. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Wall K. Serum amino acids in fibrositis/fibromyalgia syndrome. J Rheumatol 1989;19:158-63.
33. Houvenagel E, Forzy G, Cortet B, Vincent G. 5-Hydroxyindolacetic acid in cerebrospinal fluid in fibromyalgia [abstract]. Arthritis Rheum 1990;33 Suppl:S55.
34. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
35. Arendt J, Bojkowski CJ, Franey C, Wright J, Marks H. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985;60:1166-73.
36. Bojkowski CJ, Arendt J. Annual changes in 6-sulphatoxymelatonin excretion in man. Acta Endocrinol (Copenh) 1988;117:470-6.
37. Markey SP, Higa S, Shih M, Danforth DN, Tamarkin L. The correlation between human plasma melatonin levels and urinary 6-sulphatoxymelatonin excretion. Clin Chim Acta 1985;150:221-5.
38. McCarty DJ Jr, Gatter RA, Steele AD. A twenty-pound dolorimeter for quantification of articular tenderness. Arthritis Rheum 1968;11:696-8.
39. Burckhardt CS, Archenholtz B, Mannerkopi K, Bjelle A. Quality of life of Swedish women with fibromyalgia syndrome, rheumatoid arthritis or systemic lupus erythematosus. J Musculoskeletal Pain 1993;1:199-207.
40. Flanagan JC. A research approach to improving our quality of life. Am Psychol 1978;33:138-47.
41. Neumann L, Buskila D. Measuring the quality of life of women with fibromyalgia: a Hebrew version of the scale (QOLS). Pain 1997;5:5-17.
42. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia Impact Questionnaire. Development and validation. J Rheumatol 1991;18:728-33.
43. Buskila D Neumann L. Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire. J Rheumatol 1996;23:903-6.
44. Brzezinski A. Melatonin in humans. New Engl J Med 1997;336:186-95.
45. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18:598-603.
46. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-8.
47. Rommel T, Demisch L. Influence of chronic beta-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension. J Neurol Transm Gen Sect 1994;95:39-48.